Background: Asthma is a major public health problem in developed countries. In Canada, the prevalence of asthma is … of asthma in Canada to be between $Can504 million and $Can648 million (1990 dollars). 61% of all asthma costs were direct … productivity loss and level of function related to severity of asthma symptoms, and briefly review the published data on the role …

outcomes management information in developing and implementing interventions to improve the quality of care in asthma. Study … design: Prospective study. Patients and methods: Adult patients with moderate or severe asthma enrolled in sixteen … emergency room visits, canceled activities per month because of asthma, asthma attacks per month, and work days lost in the past …

Patient adherence to self-management strategies is a major issue in asthma, as in other chronic diseases. Adherence … time. While asthma self-management strategies are undoubtedly effective, many patients make serious self-management errors … during an attack and do not put into practice the self-management knowledge they possess. In asthma, adverse social, economic …

Objective: To determine the economic impact of an asthma education programme. Design and setting: The study was … population-based and used claims data to determine changes in the resources used by identified patients with asthma 9 months … before (January 1997 to September 1997) and 9 months after (January 1998 to September 1998) the implementation of the asthma …

symptoms in patients with severe asthma. However, it is well established that there are a number of undesirable adverse effects … reduced oral steroid usage in oral steroid-dependent patients. Design: A 21- to 35-day run-in period allowed asthma stability …) with severe oral steroid-dependent asthma (5 mg/day oral prednisolone and >=800 microg/day inhaled steroid) were enrolled …

Asthma is the most common chronic disorder in industrialised nations, with over 100 million people worldwide affected … used to treat asthma. They function by selectively competing for the leukotriene receptor sites, thereby blocking their … Asthma treatment guidelines have clarified the role of leukotriene modifiers in the management of asthma in adults and …

tolerated treatment option for patients with asthma. We compared the cost effectiveness from a societal perspective of this one …: Adolescents and adults with asthma (n = 2143; mean forced expiratory volume in 1 second [FEV1] 73% predicted; mean inhaled … asthma in Italy, Germany, France and the UK. SMART provided a reduction in the number of severe exacerbations per patient per …

-adrenoceptor agonist (LABA) for patients with asthma is more effective than the use of ICS alone in equivalent or higher doses, as … assessment of the cost effectiveness of ICS plus LABA combination therapy for asthma. A systematic literature research was …

, versus an oral leukotriene receptor antagonist, zafirlukast 20mg twice daily, in patients with persistent asthma currently … persistent asthma were treated with either fluticasone propionate 88microg twice daily or zafirlukast 20mg twice daily. All … fluticasone propionate 88microg twice daily as first-line treatment in patients with persistent asthma previously treated with …

Objective: To compare the expected costs of treating patients with asthma with versus without inhaled anti … MarketScan database. Patients and Participants: 7466 continuously enrolled patients with asthma. Interventions: Treatment with … pharmaceutical expenditures; and 2. asthma-related expenditures in the 1996 calendar year. Results: If all patients had been treated …